Li, J.; Huang, D.; Liao, W.; Wang, Y.; Liu, Y.; Luan, P.
Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models. Pharmaceutics 2025, 17, 177.
https://doi.org/10.3390/pharmaceutics17020177
AMA Style
Li J, Huang D, Liao W, Wang Y, Liu Y, Luan P.
Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models. Pharmaceutics. 2025; 17(2):177.
https://doi.org/10.3390/pharmaceutics17020177
Chicago/Turabian Style
Li, Jun, Dongqing Huang, Wanchen Liao, Yulin Wang, Yibiao Liu, and Ping Luan.
2025. "Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models" Pharmaceutics 17, no. 2: 177.
https://doi.org/10.3390/pharmaceutics17020177
APA Style
Li, J., Huang, D., Liao, W., Wang, Y., Liu, Y., & Luan, P.
(2025). Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models. Pharmaceutics, 17(2), 177.
https://doi.org/10.3390/pharmaceutics17020177